Ahmed Vachiat1, Mpiko Ntsekhe2, Farrel Hellig3. 1. Division of Cardiology, University of Cape Town, Cape Town, South Africa; Wits Donald Gordon Medical Centre, University of the Witwatersrand, Milpark Hospital, Johannesburg, South Africa. Email: ahmedvachiat@gmail.com. 2. Division of Cardiology, University of Cape Town, Cape Town, South Africa. 3. Division of Cardiology, University of Cape Town, Cape Town, South Africa; Sunninghill Hospital, Sunward Park Hospital, Johannesburg, South Africa.
Abstract
AIM: The aim was to assess the safety and efficacy of rotational atherectomy followed by drug-eluting balloon (DEB) in patients with a high risk of bleeding. METHODS: A retrospective review was carried out of hospital records of consecutive patients who underwent the hybrid procedure. RESULTS: The average age of the 23 patients was 74 years. Risk factors for bleeding included renal failure (35%), oral anticoagulation use (26%) and peptic ulcer disease (35%). All patients had procedural success. No bleeding was reported over the 24-month follow-up period. Dual antiplatelet therapy was stopped successfully in six patients (26%) at three months. Two patients had confirmed target-lesion failure (restenosis). Two patients died over the study period but the cause of death was not known to be cardiovascular disease related. CONCLUSIONS: For patients at high risk of bleeding who require rotablation, the use of a drug-eluting balloon may be a safe, effective alternative.
AIM: The aim was to assess the safety and efficacy of rotational atherectomy followed by drug-eluting balloon (DEB) in patients with a high risk of bleeding. METHODS: A retrospective review was carried out of hospital records of consecutive patients who underwent the hybrid procedure. RESULTS: The average age of the 23 patients was 74 years. Risk factors for bleeding included renal failure (35%), oral anticoagulation use (26%) and peptic ulcer disease (35%). All patients had procedural success. No bleeding was reported over the 24-month follow-up period. Dual antiplatelet therapy was stopped successfully in six patients (26%) at three months. Two patients had confirmed target-lesion failure (restenosis). Two patients died over the study period but the cause of death was not known to be cardiovascular disease related. CONCLUSIONS: For patients at high risk of bleeding who require rotablation, the use of a drug-eluting balloon may be a safe, effective alternative.
Authors: P Hoppmann; S Kufner; S Cassese; J Wiebe; S Schneider; S Pinieck; L Scheler; I Bernlochner; M Joner; H Schunkert; K-L Laugwitz; A Kastrati; R A Byrne Journal: Catheter Cardiovasc Interv Date: 2015-12-28 Impact factor: 2.692
Authors: I Moussa; C Di Mario; J Moses; B Reimers; L Di Francesco; G Martini; J Tobis; A Colombo Journal: Circulation Date: 1997-07-01 Impact factor: 29.690
Authors: Philip Urban; Ian T Meredith; Alexandre Abizaid; Stuart J Pocock; Didier Carrié; Christoph Naber; Janusz Lipiecki; Gert Richardt; Andres Iñiguez; Philippe Brunel; Mariano Valdes-Chavarri; Philippe Garot; Suneel Talwar; Jacques Berland; Mohamed Abdellaoui; Franz Eberli; Keith Oldroyd; Robaayah Zambahari; John Gregson; Samantha Greene; Hans-Peter Stoll; Marie-Claude Morice Journal: N Engl J Med Date: 2015-10-14 Impact factor: 91.245
Authors: U Dietz; H J Rupprecht; O Ekinci; T Dill; R Erbel; K H Kuck; R Abdollahnia; G Rippin; J Meyer; C Hamm Journal: Catheter Cardiovasc Interv Date: 2001-07 Impact factor: 2.692
Authors: Tuomas T Rissanen; Sanna Uskela; Antti Siljander; Jussi M Kärkkäinen; Pirjo Mäntylä; Juha Mustonen; Jaakko Eränen Journal: J Interv Cardiol Date: 2017-01-23 Impact factor: 2.279